News  |  Business  

Why Amgen thinks Celgene’s Psoriasis drug Otezla is worth $13.4 Billion

By Bloomberg |   30 August 2019   |   2:42 pm  
In this article:

You may also like

12 hours ago
The devaluation of the naira against the dollar has plunged Nigerians into a deep socio-economic depression. The price of basic foodstuffs can double or even triple in the same day.
1 day ago
The number of foreign direct investment projects in Europe fell 4 percent in 2023 compared to the previous year, the first decline since the pandemic.
1 day ago
China's minister of commerce is in Europe for a week-long trip, with a focus on pushing back against accusations of unfair state subsidies in the Chinese electric vehicle sector.